| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0271678X20910038 |
| P698 | PubMed publication ID | 32169011 |
| P50 | author | Hanne Demant Hansen | Q27490907 |
| Hsiao-Ying Wey | Q90309686 | ||
| P2093 | author name string | Christin Y Sander | |
| P2860 | cites work | Dopamine in motivational control: rewarding, aversive, and alerting | Q22251253 |
| Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation | Q24564739 | ||
| Simultaneous fMRI-PET of the opioidergic pain system in human brain | Q24580478 | ||
| Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist | Q24644854 | ||
| The Brain on Drugs: From Reward to Addiction | Q26798096 | ||
| Neurophysiological investigation of the basis of the fMRI signal | Q27860853 | ||
| Functional connectivity in the motor cortex of resting human brain using echo-planar MRI | Q27860856 | ||
| Vision 20/20: Magnetic resonance imaging-guided attenuation correction in PET/MRI: Challenges, solutions, and opportunities | Q28074576 | ||
| A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System | Q28125944 | ||
| Functional mapping of the human visual cortex by magnetic resonance imaging | Q28246801 | ||
| Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging | Q28283786 | ||
| High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action | Q28374171 | ||
| Speech-induced striatal dopamine release is left lateralized and coupled to functional striatal circuits in healthy humans: a combined PET, fMRI and DTI study | Q28707279 | ||
| Activation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes. | Q30364526 | ||
| A receptor-based model for dopamine-induced fMRI signal | Q30434854 | ||
| Whole-brain circuit dissection in free-moving animals reveals cell-specific mesocorticolimbic networks | Q30559271 | ||
| Glutamate and glutamine: a review of in vivo MRS in the human brain | Q30677120 | ||
| Functional magnetic resonance imaging based on changes in vascular space occupancy. | Q30813584 | ||
| MR Imaging-Guided Attenuation Correction of PET Data in PET/MR Imaging | Q31054295 | ||
| Methods for cleaning the BOLD fMRI signal. | Q31148361 | ||
| Magnetic resonance imaging of perfusion using spin inversion of arterial water | Q33273514 | ||
| Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity. | Q53397658 | ||
| μ-opioid receptor system mediates reward processing in humans. | Q55235446 | ||
| Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD | Q56876541 | ||
| Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM) | Q57138278 | ||
| Altered connectivity between striatal and extrastriatal regions in patients with schizophrenia on maintenance antipsychotics: an [ F]fallypride PET and functional MRI study | Q57174055 | ||
| Imaging glutamate redistribution after acute N-acetylcysteine administration: A simultaneous PET/MR study | Q57185336 | ||
| CRISPR/Cas9-mediated disruption of SHANK3 in monkey leads to drug-treatable autism-like symptoms | Q57457546 | ||
| Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [C]-(+)-PHNO Positron Emission Tomography and Functional Magnetic Resonance Imaging Study | Q57461556 | ||
| Hybrid PET/MRI Methodology | Q57498309 | ||
| Mesolimbic Dopamine Function Is Related to Salience Network Connectivity: An Integrative Positron Emission Tomography and Magnetic Resonance Study | Q58604458 | ||
| Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity | Q58798205 | ||
| Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast | Q59299620 | ||
| Striatal dopamine deficits predict reductions in striatal functional connectivity in major depression: a concurrent C-raclopride positron emission tomography and functional magnetic resonance imaging investigation | Q59799663 | ||
| Increased cerebral blood flow after single dose of antipsychotics in healthy volunteers depends on dopamine D2 receptor density profiles | Q60440789 | ||
| Reduced acquisition time PET pharmacokinetic modelling using simultaneous ASL–MRI: proof of concept | Q61945024 | ||
| Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms | Q64085157 | ||
| The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation | Q64264112 | ||
| New statistics on the cost of new drug development and the trouble with CNS drugs | Q86310306 | ||
| MR-assisted PET motion correction in simultaneous PET/MRI studies of dementia subjects | Q88002001 | ||
| The Influence of Dopamine on Cognitive Flexibility Is Mediated by Functional Connectivity in Young but Not Older Adults | Q88784001 | ||
| Aerobic exercise modulates anticipatory reward processing via the μ-opioid receptor system | Q89048342 | ||
| Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development | Q90198060 | ||
| Changes in Endogenous Dopamine Induced by Methylphenidate Predict Functional Connectivity in Nonhuman Primates | Q90366205 | ||
| In vivo biased agonism at 5-HT1A receptors: characterisation by simultaneous PET/MR imaging | Q90376541 | ||
| In vivo metabotropic glutamate receptor 5 availability-associated functional connectivity alterations in drug-naïve young adults with major depression | Q90554439 | ||
| Simultaneous task-based BOLD-fMRI and [18-F] FDG functional PET for measurement of neuronal metabolism in the human visual cortex | Q90923405 | ||
| Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge | Q91247411 | ||
| Dopaminergic Mechanisms Underlying Normal Variation in Trait Anxiety | Q91429108 | ||
| Dynamic changes in cerebral and peripheral markers of glutamatergic signaling across the human sleep-wake cycle | Q91874119 | ||
| Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging | Q91926628 | ||
| The 5-HT1A receptor: Signaling to behavior | Q91955928 | ||
| Serotonin Transporter Binding in the Human Brain After Pharmacological Challenge Measured Using PET and PET/MR | Q92237637 | ||
| Summary of the First ISMRM-SNMMI Workshop on PET/MRI: Applications and Limitations | Q92254520 | ||
| PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations | Q92607126 | ||
| Relationship of self-transcendence traits with in vivo dopamine D2/3 receptor availability and functional connectivity: An [18 F]fallypride PET and fMRI study | Q92806427 | ||
| Receptor-Enriched Analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA | Q92891791 | ||
| Whole-Body Integrated [68Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of Reference | Q93090440 | ||
| Next generation research applications for hybrid PET/MR and PET/CT imaging using deep learning | Q93117722 | ||
| A linear model for estimation of neurotransmitter response profiles from dynamic PET data | Q33964638 | ||
| PET physiological measurements using constant infusion | Q34088965 | ||
| Early development of arterial spin labeling to measure regional brain blood flow by MRI | Q34127585 | ||
| A review of the development of Vascular-Space-Occupancy (VASO) fMRI. | Q34127767 | ||
| IRON fMRI measurements of CBV and implications for BOLD signal | Q34142546 | ||
| Finding the BOLD effect in brain images | Q34152030 | ||
| Nonoxidative glucose consumption during focal physiologic neural activity | Q34171272 | ||
| 5-HT radioligands for human brain imaging with PET and SPECT | Q34192729 | ||
| Pharmacologic magnetic resonance imaging (phMRI): imaging drug action in the brain | Q34229087 | ||
| The development and future of perfusion fMRI for dynamic imaging of human brain activity. | Q34259168 | ||
| Simultaneous PET-MRI reveals brain function in activated and resting state on metabolic, hemodynamic and multiple temporal scales | Q34366546 | ||
| Dynamic functional imaging of brain glucose utilization using fPET-FDG. | Q34425194 | ||
| Distinctive in vitro signal transduction profile of NLX-112, a potent and efficacious serotonin 5-HT1A receptor agonist | Q34557860 | ||
| Separating slow BOLD from non-BOLD baseline drifts using multi-echo fMRI. | Q34674669 | ||
| Voxelwise lp-ntPET for detecting localized, transient dopamine release of unknown timing: sensitivity analysis and application to cigarette smoking in the PET scanner | Q35001355 | ||
| Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden | Q35007853 | ||
| Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans | Q35125148 | ||
| Dopaminergic modulation of synaptic transmission in cortex and striatum | Q35282100 | ||
| Remifentanil administration reveals biphasic phMRI temporal responses in rat consistent with dynamic receptor regulation | Q35748337 | ||
| Medial prefrontal cortex serotonin 1A and 2A receptor binding interacts to predict threat-related amygdala reactivity | Q36038871 | ||
| Imaging the dopamine system with in vivo [11C]raclopride displacement studies: understanding the true mechanism | Q36136737 | ||
| Magnetization Transfer Contrast and Chemical Exchange Saturation Transfer MRI. Features and analysis of the field-dependent saturation spectrum | Q36354566 | ||
| Metabolic connectivity mapping reveals effective connectivity in the resting human brain | Q36483286 | ||
| DREADDs for Neuroscientists | Q36595793 | ||
| Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study | Q36623197 | ||
| Imaging Agonist-Induced D2/D3 Receptor Desensitization and Internalization In Vivo with PET/fMRI. | Q36690726 | ||
| Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction? | Q36723314 | ||
| A combined [11C]diprenorphine PET study and fMRI study of acupuncture analgesia. | Q36881859 | ||
| Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. | Q36887124 | ||
| Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers | Q36906636 | ||
| Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI | Q36990782 | ||
| Detection of dopamine neurotransmission in "real time". | Q37023156 | ||
| Dopamine D1 signaling organizes network dynamics underlying working memory | Q37056095 | ||
| Energetic cost of brain functional connectivity | Q37103911 | ||
| Toward Implementing an MRI-Based PET Attenuation-Correction Method for Neurologic Studies on the MR-PET Brain Prototype | Q37241170 | ||
| The 5-HT1A receptor in Major Depressive Disorder | Q37538381 | ||
| Presynaptic Serotoninergic Regulation of Emotional Processing: A Multimodal Brain Imaging Study. | Q37661822 | ||
| Mapping glutamate in subcortical brain structures using high-resolution GluCEST MRI. | Q37723687 | ||
| Radioligands for the dopamine receptor subtypes | Q38166968 | ||
| Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging | Q38810544 | ||
| Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites | Q38832010 | ||
| A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients. | Q39092307 | ||
| Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective | Q41594601 | ||
| Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain | Q41595331 | ||
| A regularized full reference tissue model for PET neuroreceptor mapping. | Q41654553 | ||
| Men with high serotonin 1B receptor binding respond to provocations with heightened amygdala reactivity | Q42698408 | ||
| MRI-assisted PET motion correction for neurologic studies in an integrated MR-PET scanner | Q42778639 | ||
| Amphetamine induced endogenous opioid release in the human brain detected with [¹¹C]carfentanil PET: replication in an independent cohort | Q44344726 | ||
| Dissociable Roles of Cerebral μ-Opioid and Type 2 Dopamine Receptors in Vicarious Pain: A Combined PET-fMRI Study | Q44345924 | ||
| Using [11C]diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: clinical and preclinical studies | Q44346587 | ||
| A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems | Q44525590 | ||
| In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride | Q44830953 | ||
| 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra | Q46170483 | ||
| Small Molecule Receptor Ligands for PET Studies of the Central Nervous System-Focus on G Protein Coupled Receptors | Q46318426 | ||
| Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457. | Q46514325 | ||
| Effect of Citalopram on Emotion Processing in Humans: A Combined 5-HT1A [11C]CUMI-101 PET and Functional MRI Study. | Q46526889 | ||
| ntPET: a new application of PET imaging for characterizing the kinetics of endogenous neurotransmitter release. | Q46802303 | ||
| Molecular and functional PET-fMRI measures of placebo analgesia in episodic migraine: Preliminary findings | Q47097600 | ||
| Probing the association between serotonin-1A autoreceptor binding and amygdala reactivity in healthy volunteers | Q47206511 | ||
| Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany. | Q47608030 | ||
| Functional Characterization of 5-HT1B Receptor Drugs in Nonhuman Primates Using Simultaneous PET-MR. | Q47709535 | ||
| TRIMAGE: A dedicated trimodality (PET/MR/EEG) imaging tool for schizophrenia. | Q47846707 | ||
| Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivity. | Q47970892 | ||
| Brain-wide Mapping of Endogenous Serotonergic Transmission via Chemogenetic fMRI. | Q48001244 | ||
| Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9. | Q48147422 | ||
| Parallel buprenorphine phMRI responses in conscious rodents and healthy human subjects. | Q48182012 | ||
| Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease. | Q48353766 | ||
| Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. | Q48385577 | ||
| An extended simplified reference tissue model for the quantification of dynamic PET with amphetamine challenge. | Q48442559 | ||
| Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. | Q48823706 | ||
| Simplified reference tissue model for PET receptor studies. | Q48832665 | ||
| Anatomy, Functionality, and Neuronal Connectivity with Manganese Radiotracers for Positron Emission Tomography. | Q49356275 | ||
| Zero TE-based pseudo-CT image conversion in the head and its application in PET/MR attenuation correction and MR-guided radiation therapy planning. | Q49861179 | ||
| Effects of flow changes on radiotracer binding: Simultaneous measurement of neuroreceptor binding and cerebral blood flow modulation. | Q50501658 | ||
| The 5-HT1B receptor - a potential target for antidepressant treatment. | Q51739456 | ||
| Cerebral blood flow predicts differential neurotransmitter activity. | Q52671076 | ||
| P304 | page(s) | 271678X20910038 | |
| P577 | publication date | 2020-03-13 | |
| P1433 | published in | Journal of Cerebral Blood Flow & Metabolism | Q14663525 |
| P1476 | title | Advances in simultaneous PET/MR for imaging neuroreceptor function |
Search more.